Aamir Nazir1, Neha Kumari, Nitan Bharti Gupta, Rajesh Gupta, Ashima Chandel, Abi C. Varghese
Aamir Nazir1, Neha Kumari1*, Nitan Bharti Gupta2, Rajesh Gupta2, Ashima Chandel2, Abi C. Varghese2
1Department of Pharmaceutics, Sri Sai College of Pharmacy, Badhani, Pathankot 145001, Punjab, India.
2Chandigarh University of Pharma Science (UIPS), Chandigarh - Ludhiana Highway, Gharuan, Mohali, Punjab, India.
Volume - 13,
Issue - 3,
Year - 2023
The focal point of this survey is to give an outline of the chitosan based nanoparticles for different non-parenteral applications and furthermore to put a focus on flow research including supported delivery and mucoadhesive chitosan measurement structures. Chitosan is a biodegradable, biocompatible polymer viewed as safe for human dietary use and endorsed for wound dressing applications. Chitosan has been utilized as a transporter in polymeric nanoparticles for drug conveyance through different courses of organization. Chitosan has synthetic useful gatherings that can be adjusted to accomplish explicit objectives, making it a polymer with an enormous scope of expected applications. Nanoparticles (NP) ready with chitosan and chitosan subsidiaries ordinarily have a positive surface charge and mucoadhesive properties to such an extent that can hold fast to bodily fluid films and delivery the medication payload in a supported delivery way. Chitosan-based NP have different applications in non-parenteral medication conveyance for the therapy of malignant growth, gastrointestinal illnesses, aspiratory sicknesses, drug conveyance to the mind and visual contaminations which will be exemplified in this survey. Chitosan shows low poisonousness both in vitro and some in vivo models. This survey investigates ongoing exploration on chitosan based NP for non-parenteral medication conveyance, chitosan properties, adjustment, poisonousness, pharmacokinetics and preclinical examinations.
Cite this article:
Aamir Nazir1, Neha Kumari, Nitan Bharti Gupta, Rajesh Gupta, Ashima Chandel, Abi C. Varghese. Recent Advances on Chitosan Nanoparticles. Asian Journal of Pharmaceutical Research. 2023; 13(3):158-2. doi: 10.52711/2231-5691.2023.00030
Aamir Nazir1, Neha Kumari, Nitan Bharti Gupta, Rajesh Gupta, Ashima Chandel, Abi C. Varghese. Recent Advances on Chitosan Nanoparticles. Asian Journal of Pharmaceutical Research. 2023; 13(3):158-2. doi: 10.52711/2231-5691.2023.00030 Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2023-13-3-4
1. Rampino, A. Borgogna, M. Blasi, P. Bellich, B. Cesàro, A. Chitosan nanoparticles: Preparation, size evolution and stability. Int. J. Pharm. 2013; 455: 219–228.doi.org/10.1016/j.ijpharm.2013.07.034.
2. Nagpal, K. Singh, S.K. Mishra, D.N. Chitosan Nanoparticles: A Promising System in Novel Drug Delivery. Chem. Pharm. Bull. 2010; 58 : 1423–1430.doi.org/ 10.1248/cpb.58.1423.
3. Vårum, K.M. Ottøy, M.H. Smidsrød, O. Water-solubility of partially N-acetylated chitosans as a function of pH: Effect of chemical composition and depolymerisation. Carbohydr. Polym. 1994; 25: 65–70.Doi.org/10.1016/0144-8617(94)90140-6.
4. Chen, M.C, Mi, F.L. Liao, Z.X. Hsiao, C.W. Sonaje, K. Chung, M.F.; Hsu, L.W.; Sung, H.W. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules: Adv. Drug Deliv. Rev. 2013; 65: 865–879.Doi.org/10.1016/j.addr.2012.10.010.
5. Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An Overview of Chitosan Nanoparticles and its Applications in Non Parentral Drug Delivery. Pharmaceutics. 2017; 53: 34-43. Doi.org/10.3390/pharmaceutics9040053.
6. Frank Alexis, Eric M. Pridgen, Robert Langer, and Omid C. Farokhzad; Nanoparticle Technologies for Cancer Therapy; M. Scha¨fer- Korting (ed.), Drug Delivery, Handbook of Experimental Pharmacology 197; Springer-Verlag Berlin Heidelberg 2010. Doi.org/10.1016/0168-3659(93)90097-O.
7. Baldrick, P. 2010.The safety of chitosan as a pharmaceutical excipient. Regul. Toxicol. Pharmacol.,56:290–299. doi.org/10.1016/S0168-3659(01)00486-2.
8. Kean, T, and Thanou M. 2010. Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug Deliv. Rev., 62: 3–11.doi.org/10.1067/ cpb.58.14232.2010.08.056
9. Alishahi, A. Mirvaghefi, A. Tehrani, M.R. Farahmand, H.; Koshio, S.; Dorkoosh, F.A.; Elsabee, M.Z. Chitosan nanoparticle to carry vitamin C through the gastrointestinal tract and induce the non-specific immunity system of rainbow trout (Oncorhynchus mykiss). Carbohydr. Polym. 2011; 86: 142–146. doi.org/10.1016/j.carbpol.2011.04.028.
10. Hembram, K.C. Prabha, S.; Chandra, R. Ahmed, B.; Nimesh, S. Advances in preparation and characterization of chitosan nanoparticles for therapeutics: Artif. Cells Nanomed. Biotechnol. 2014; 1401: 1–10. doi.org/10.3109/21691401.2014.948548
11. Gonçalves, I.C. Henriques, P.C. Seabra, C.L. Martins, M.C.L. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection: Expert Rev. Anti. Infect. Ther. 2014; 12: 981–992.Doi.org/10.1586/14787210.2014.930663
12. Zhao, K. Shi, X. Zhao, Y. Wei, H. Sun, Q.; Huang, T. Zhang, X.Wang, Y. Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles.: Vaccine 2011; 29:8549–8556. doi.org/10.1016/j.vaccine.2011.09.029.
13. Zhuo, Y.; Han, J. Tang, L.Liao, N. Gui, G.-F.; Chai, Y.-Q.; Yuan, R. Quenching of the emission of peroxydisulfate system by ferrocene functionalized chitosan nanoparticles: A sensitive “signal off” electrochemiluminescence immunosensor: Sens. Actuators B Chem. 2014; 192: 791–795. Doi.org/10.1016/j.snb.2013.11.032.
14. Maitra, A. Ghosh, P.K. De, T.K. Sahoo, S.K. Process for the Preparation of Highly Monodispersed Polymeric Hydrophilic Nanoparticles. US 5874111 A, 7 January 1999.doi.org/10.2147/nano.2006.1.2.181
15. Wang, Y. Wang, X. Luo, G.; Dai, Y. Adsorption of bovin serum albumin (BSA) onto the magnetic chitosan nanoparticles prepared by a microemulsion system: Bioresour. Technol. 2008; 99: 3881–3884.doi.org/10.1016/j.biortech.2007.08.017.
16. El-Shabouri, M.H. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int. J. Pharm. 2002; 249: 101–108.
17. Zeinab Sadat, S. Hamed, S.-K. Mohammad, I. Mohammad, A.; Azizollah, N. Exploring the effect of formulation parameters on the particle size of carboxymethyl chitosan nanoparticles prepared via reverse micellar crosslinking: J. Microencapsul. 2017; 34: 270–279.doi.org/10.1080/02652048.2017.1321047.
18. Liu, C. Tan, Y. Liu, C. Chen, X. Yu, L. Preparations, characterizations and applications of Chitosan-based nanoparticles. J. Ocean Univ. China 2007; 6: 237–243.doi.org/10.1007/s11802-007-0237-9
19. Mitra, S. Gaur, U. Ghosh, P.C. Maitra, A.N. Tumour targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier. J. Control. Release 2001; 74: 317–323.doi.org/10.1016/S0168-3659(01)00342-X.
20. Bellich, B. D’Agostino, I. Semeraro, S. Gamini, A. Cesàro, A. “The good, the bad and the ugly” of chitosans. Mar. Drugs 2016; 14: 99. doi.org/10.3390/md14050099.
21. Key, J. Park, K. Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy. Int. J. Mol. Sci. 2017; 18: E594.doi.org/10.3390/ijms18030594.
22. Swierczewska, M. Han, H.S. Kim, K. Park, J.H.; Lee, S. Polysaccharide-based nanoparticles for theranostic nanomedicine. Adv. Drug Deliv. Rev. 2016; 99 Pt A: 70–84. doi.org/10.1016/j.addr.2015.11.015.